Lamothe Jeffrey G. 4
4 · Aptevo Therapeutics Inc. · Filed Jul 21, 2025
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock (post-reverse split May ACTIVE)
2025-07-17+5→ 6 total - Exercise/Conversion
Restricted Stock Unit
2025-07-17−5→ 12 total→ Common Stock (17 underlying)
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On July 17, 2024, the reporting person was granted 12,825 (17 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025.